Sponsored content Eye health is something many of us take for granted. But looking after our eyes is important for ...

HealthDay News — Socioeconomic factors are linked to an increased risk for age-related macular degeneration (AMD), according to a study published online July 1 in Health Data Science.

Neuralink Corp., Elon Musk’s brain-computer venture, and rivals like Science Corp. are making strides in technology that ...

This drug is the world’s first-ever CRISPR/Cas13 RNA-editing therapy for clinical use in treating neovascular age-related macular degeneration (nAMD ... promising results from the first-in-human ...

Sight Care is an all-new vision support complex that has become a topic of discussion in the market over the past few ...

You may have seen advertisements claiming to eliminate the need for eyeglasses through vision therapy or vision training – ...

The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.

The FDA has cleared its first light-based therapy for dry age-related macular degeneration—which the agency described as ...

PulseSight plans to submit a phase I clinical trial authorization (CTA) by the end the year, to be closely followed by a phase II proof-of-concept to demonstrate the efficacy and the safety of its ...

The Eyes Have It is a partnership of Macular Society, Fight for Sight/Vision Foundation ... the vision of someone with increasingly severe levels of age-related macular degeneration. The device ...

Have your parents or grandparents ever had trouble driving, reading or recognizing faces? They might be suffering from age-related macular degeneration, a progressive disease afflicting about 11 ...

They can recommend a treatment to keep you seeing clearly even with aging eyes. Age-related macular degeneration affects your central vision but leaves your peripheral vision unchanged.